• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型 microRNA 在乳腺癌和前列腺癌发病机制中的作用。

The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.

机构信息

Department of General Hygiene, F. Erismann Institute of Public Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia.

Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.

出版信息

Int J Mol Sci. 2023 Jan 19;24(3):1980. doi: 10.3390/ijms24031980.

DOI:10.3390/ijms24031980
PMID:36768298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916830/
Abstract

Micro ribonucleic acids (microRNAs or miRNAs) form a distinct subtype of non-coding RNA and are widely recognized as one of the most significant gene expression regulators in mammalian cells. Mechanistically, the regulation occurs through microRNA binding with its response elements in the 3'-untranslated region of target messenger RNAs (mRNAs), resulting in the post-transcriptional silencing of genes, expressing target mRNAs. Compared to small interfering RNAs, microRNAs have more complex regulatory patterns, making them suitable for fine-tuning gene expressions in different tissues. Dysregulation of microRNAs is well known as one of the causative factors in malignant cell growth. Today, there are numerous data points regarding microRNAs in different cancer transcriptomes, the specificity of microRNA expression changes in various tissues, and the predictive value of specific microRNAs as cancer biomarkers. Breast cancer (BCa) is the most common cancer in women worldwide and seriously impairs patients' physical health. Its incidence has been predicted to rise further. Mounting evidence indicates that microRNAs play key roles in tumorigenesis and development. Prostate cancer (PCa) is one of the most commonly diagnosed cancers in men. Different microRNAs play an important role in PCa. Early diagnosis of BCa and PCa using microRNAs is very useful for improving individual outcomes in the framework of predictive, preventive, and personalized (3P) medicine, thereby reducing the economic burden. This article reviews the roles of different types of microRNA in BCa and PCa progression.

摘要

微小核糖核酸 (microRNAs 或 miRNAs) 是一种独特的非编码 RNA 亚型,被广泛认为是哺乳动物细胞中最重要的基因表达调控因子之一。从机制上讲,这种调节是通过 microRNA 与其靶信使 RNA(mRNA)3'-非翻译区中的反应元件结合而发生的,导致基因的转录后沉默,表达靶 mRNA。与小干扰 RNA 相比,microRNAs 具有更复杂的调节模式,使其适合在不同组织中微调基因表达。microRNAs 的失调是恶性细胞生长的一个已知原因。如今,不同癌症转录组中有大量关于 microRNAs 的数据点,各种组织中 microRNA 表达变化的特异性,以及特定 microRNAs 作为癌症生物标志物的预测价值。乳腺癌 (BCa) 是全世界女性中最常见的癌症,严重损害了患者的身体健康。预计其发病率还会进一步上升。越来越多的证据表明,microRNAs 在肿瘤发生和发展中发挥着关键作用。前列腺癌 (PCa) 是男性最常见的癌症之一。不同的 microRNAs 在 PCa 中发挥着重要作用。使用 microRNAs 早期诊断 BCa 和 PCa 对于改善预测、预防和个体化 (3P) 医学框架下的个体预后非常有用,从而降低经济负担。本文综述了不同类型的 microRNA 在 BCa 和 PCa 进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/06f3fc9a6bb5/ijms-24-01980-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/9d4f21e023cf/ijms-24-01980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/1ed35118af01/ijms-24-01980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/3551d4c2d2b1/ijms-24-01980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/7f5a72e8405d/ijms-24-01980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/cd5b768e1ef5/ijms-24-01980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/a489d65cd460/ijms-24-01980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/dfcc404b677d/ijms-24-01980-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/2bbc84b8a2ce/ijms-24-01980-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/06f3fc9a6bb5/ijms-24-01980-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/9d4f21e023cf/ijms-24-01980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/1ed35118af01/ijms-24-01980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/3551d4c2d2b1/ijms-24-01980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/7f5a72e8405d/ijms-24-01980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/cd5b768e1ef5/ijms-24-01980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/a489d65cd460/ijms-24-01980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/dfcc404b677d/ijms-24-01980-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/2bbc84b8a2ce/ijms-24-01980-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9091/9916830/06f3fc9a6bb5/ijms-24-01980-g009.jpg

相似文献

1
The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.不同类型 microRNA 在乳腺癌和前列腺癌发病机制中的作用。
Int J Mol Sci. 2023 Jan 19;24(3):1980. doi: 10.3390/ijms24031980.
2
MicroRNA-9 and breast cancer.微小 RNA-9 与乳腺癌。
Biomed Pharmacother. 2020 Feb;122:109687. doi: 10.1016/j.biopha.2019.109687. Epub 2019 Dec 30.
3
MicroRNAs and prostate cancer.微小 RNA 与前列腺癌。
Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):363-9. doi: 10.1093/abbs/gmq038.
4
TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.TATDN1 通过靶向 microRNA-140-3p 促进乳腺癌的发生和发展。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5293-5300. doi: 10.26355/eurrev_201906_18196.
5
Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.用于前列腺癌转移的生物标志物 microRNAs:通过网络脆弱性分析模型筛选。
J Transl Med. 2018 May 21;16(1):134. doi: 10.1186/s12967-018-1506-7.
6
Implications of microRNA dysregulation in the development of prostate cancer.微小 RNA 失调在前列腺癌发展中的意义。
Reproduction. 2017 Oct;154(4):R81-R97. doi: 10.1530/REP-17-0322.
7
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.微小RNA表达与基因调控驱动PyMT小鼠乳腺癌的进展和转移。
Breast Cancer Res. 2016 Jul 22;18(1):75. doi: 10.1186/s13058-016-0735-z.
8
Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.肿瘤抑制性微小RNA-145通过靶向人前列腺癌细胞中的SENP1诱导生长停滞。
Cancer Sci. 2015 Apr;106(4):375-82. doi: 10.1111/cas.12626. Epub 2015 Mar 16.
9
miRNAs in breast cancer tumorigenesis (Review).miRNAs 在乳腺癌发生中的作用(综述)。
Oncol Rep. 2012 Apr;27(4):903-10. doi: 10.3892/or.2011.1611. Epub 2011 Dec 23.
10
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.微小RNA 338-3p发挥肿瘤抑制作用,其表达下调与前列腺癌患者不良临床预后相关。
Mol Biol Rep. 2016 Apr;43(4):229-40. doi: 10.1007/s11033-016-3948-4. Epub 2016 Feb 23.

引用本文的文献

1
Micro RNA in Colorectal Cancer-Potential Diagnostic and Prognostic Markers-An Updated Review.结直肠癌中的微小RNA——潜在的诊断和预后标志物——最新综述
Int J Mol Sci. 2025 Sep 4;26(17):8615. doi: 10.3390/ijms26178615.
2
Non-coding RNAs as key regulators of epithelial-mesenchymal transition in breast cancer.非编码RNA作为乳腺癌上皮-间质转化的关键调节因子
Front Cell Dev Biol. 2025 Mar 25;13:1544310. doi: 10.3389/fcell.2025.1544310. eCollection 2025.
3
A new era of cancer immunotherapy: vaccines and miRNAs.癌症免疫疗法的新时代:疫苗与微小RNA

本文引用的文献

1
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.预测、预防和个性化医学框架下的抗前列腺癌保护与治疗——植物化学物质在一级、二级和三级医疗中的综合作用
EPMA J. 2022 Jul 8;13(3):461-486. doi: 10.1007/s13167-022-00288-z. eCollection 2022 Sep.
2
Dissecting the Roles of PDCD4 in Breast Cancer.剖析PDCD4在乳腺癌中的作用
Front Oncol. 2022 Jun 20;12:855807. doi: 10.3389/fonc.2022.855807. eCollection 2022.
3
Secreted miR-153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer.
Cancer Immunol Immunother. 2025 Apr 1;74(5):163. doi: 10.1007/s00262-025-04011-5.
4
Hybridization Chain Reaction-Enhanced Ultrasensitive Electrochemical Analysis of miRNAs with a Silver Nano-Reporter on a Gold Nanostructured Electrode Array.基于金纳米结构电极阵列上的银纳米报告子,利用杂交链式反应增强的miRNA超灵敏电化学分析
J Funct Biomater. 2025 Mar 12;16(3):98. doi: 10.3390/jfb16030098.
5
Sensitive and reliable lab-on-paper biosensor for label-free detection of exosomes by electrochemical impedance spectroscopy.通过电化学阻抗谱对无标记外泌体进行灵敏可靠的纸基实验室生物传感器检测。
Mikrochim Acta. 2024 Sep 24;191(10):617. doi: 10.1007/s00604-024-06644-2.
6
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.利用纳米颗粒递送 miRNA 治疗骨肉瘤。
Int J Nanomedicine. 2024 Aug 22;19:8641-8660. doi: 10.2147/IJN.S471900. eCollection 2024.
7
Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells.金纳米颗粒通过调节三阴性乳腺癌细胞中的 microRNA-155-5p,减弱干扰素-γ诱导的 SOCS1 表达和 NF-κB p65/50 活性的激活。
Front Immunol. 2023 Aug 31;14:1228458. doi: 10.3389/fimmu.2023.1228458. eCollection 2023.
8
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives.纳米技术在基于miRNA的癌症治疗中的应用:当前进展与未来展望。
Front Bioeng Biotechnol. 2023 Jul 27;11:1208547. doi: 10.3389/fbioe.2023.1208547. eCollection 2023.
9
Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.IV 期黑色素瘤患者和人黑色素瘤细胞系中常见 microRNA 生物标志物候选物的测定:一种潜在的抗黑色素瘤药物筛选模型。
Int J Mol Sci. 2023 May 23;24(11):9160. doi: 10.3390/ijms24119160.
分泌型 miR-153 控制高 Gleason 评分前列腺癌的增殖和侵袭。
Int J Mol Sci. 2022 Jun 6;23(11):6339. doi: 10.3390/ijms23116339.
4
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.植物化学物质的抗乳腺癌作用:初级、二级和三级护理。
EPMA J. 2022 Apr 14;13(2):315-334. doi: 10.1007/s13167-022-00277-2. eCollection 2022 Jun.
5
Prostate cancer treatment costs increase more rapidly than for any other cancer-how to reverse the trend?前列腺癌的治疗成本比其他任何癌症增长得都要快——如何扭转这一趋势?
EPMA J. 2022 Mar 1;13(1):1-7. doi: 10.1007/s13167-022-00276-3. eCollection 2022 Mar.
6
Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.特定生物标志物模式所反映的全身效应有助于前列腺癌管理的范式转变:一篇战略论文。
Cancers (Basel). 2022 Jan 28;14(3):675. doi: 10.3390/cancers14030675.
7
Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer.从非编码 RNA 的角度解码胰岛素样生长因子信号通路:迈向乳腺癌精准肿瘤学的一步。
J Mammary Gland Biol Neoplasia. 2022 Mar;27(1):79-99. doi: 10.1007/s10911-022-09511-z. Epub 2022 Feb 10.
8
Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer.血清 microRNAs(miR-9-5p、miR-17-5p 和 miR-148a-3p)作为乳腺癌潜在生物标志物的评估。
Biomed Res Int. 2022 Jan 24;2022:9961412. doi: 10.1155/2022/9961412. eCollection 2022.
9
Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2.miR-21-5p 抑制剂与 Aurora 激酶抑制剂协同治疗通过靶向芽生 RTK 信号拮抗剂 2 抑制乳腺癌进展。
Bioengineered. 2022 Jan;13(1):455-468. doi: 10.1080/21655979.2021.2009410.
10
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.微小RNA的miR-200家族:上皮-间质转化的精细调节因子及循环肿瘤生物标志物
Cancers (Basel). 2021 Nov 23;13(23):5874. doi: 10.3390/cancers13235874.